Hypotension during anaesthesia induction predicts postoperative cardiovascular complications, such as stroke and renal failure. 1 2 Anaesthesia risk assessment, such as ASA classification, has been used in non-cardiac surgery for predicting postoperative cardiovascular complications. 3 Nevertheless, low ASA class is not a reliable predictor of the risk of cardiovascular events. 4 Investigations such as standard cardiac echography and ECG have also failed to confirm their usefulness as predictors of perioperative cardiovascular risk. 5 6 Increased arterial stiffness is the main manifestation of arterial ageing. Pulse pressure (PP) is a rough indicator of arterial stiffness. PP variation is a robust indicator of fluid responsiveness in mechanically ventilated supine patients. 7 Presently, carotid -femoral pulse wave velocity (c-fPWV) is considered the 'gold-standard' measurement of arterial stiffness, as clearly highlighted in the expert consensus document on arterial stiffness of the European Network for Non-invasive Investigation of Large Arteries. 8 Pathophysiological implication of increased arterial stiffness is most important in the elderly, 9 and is responsible for altered homeostasis and higher risk of orthostatic hypotension. 10 Hence, an increase in arterial stiffness, especially in the elderly, can be related to haemodynamic instability during general anaesthesia. 11 Experimental models have indicated that arterial stiffness could prove valuable in evaluating the risks during anaesthesia. 12 However, clinical studies, in younger patients, have been unable to prove added value of preoperative assessment of arterial stiffness. 13 -15 We hypothesized that elderly patients with increased PWV undergo a more pronounced decrease in arterial pressure (AP) during induction of anaesthesia. The aim of the study was to establish whether elevated arterial stiffness assessed during preoperative evaluation was correlated with hypotension during induction of anaesthesia in a population aged 60 -80 yr undergoing non-cardiovascular surgery.
Methods
With the approval of Ethics Committee, this prospective study was conducted in the Department of Anaesthesiology of the Central Hospital of Nancy, between February and December 2007. During this period, assessment of PWV was proposed to all patients aged 60-80 yr who underwent a pre-surgical anaesthetic evaluation 1 month before their scheduled total hip arthroplasty surgery. Patients with a recent medical history of cardiovascular events (6 months), cardiac arrhythmia, severe cardiac impairment, or morphine treatment were excluded. After receiving the necessary information, patients gave a written consent. Information regarding health was obtained by medical history, registration of current medication, and physical examination. After clinical evaluation, patients were placed in the supine position for 10 min in a room that enabled physical and sensorial rest. Two non-invasive AP measurements were taken; the first after the 10 min rest period and the second before femoral PWV assessment (using a Physiograd w semiautomatic device). The mean of these two AP measurements was used for statistical purposes (designated as APc), and compared with the value obtained on the day of the surgery (designated as APa).
Assessment of PWV was carried out using the PulsePen device (DiaTecne srl, Milan, Italy), a validated, easy-to-use, high-fidelity device, which has been described in detail previously. 16 Composed of a tonometer and an integrated ECG unit, the PulsePen comprises a pressure probe that serves to non-invasively detect the pressure waveform by applanation tonometry. 17 Briefly, the artery surface is flattened by a slight downward pressure against the underlying rigid structures, such as bones, cartilage, or muscles. The probe is maintained perpendicular to the skin at the site where the artery reaches its highest pulsation. The probe is connected to a unit detecting the electrocardiographic signal. Both pressure and electrocardiographic signals are transmitted to a computer with a sample rate of 500 Hz by means of an optical fibre that ensures electromagnetic isolation for the patient undergoing the test. Data analysis is performed by a specially designed software. The PulsePen assesses the PWV at two intervals in a highly rapid succession. Previous studies have confirmed the method's reliability compared with invasive methods 16 and also PWV recordings with simultaneous assessment of carotid and femoral pressure waves. 18 The operator starts positioning the detector at the common carotid artery, the central detection site, while simultaneously performing ECG and tonometry. Thereafter, the same procedure is followed for the femoral artery. Aortic PWV is defined as the distance divided by the difference between the time delay of the distal pulse wave to the R wave on the ECG QRS complex and the time delay of the proximal pulse wave to R wave on the QRS complex. The distance is assessed as the distance from the suprasternal notch to the femoral artery minus the distance from the carotid artery to the suprasternal notch, using a tapemeasure located at the same site as the tonometer probe. The mean interval between carotid pressure wave acquisition and femoral pressure wave acquisition was 58 (23) s. The mean duration of the entire examination was 10 min. Since changes in AP and heart rate (HR) can alter PWV values, the PulsePen software always records the changes in AP and HR between the recording times of each PWV measurement. In the present setup, the operator repeated the test when AP and HR difference was more than 8%. For the assessment of pulse transit time (and PWV), 10 s of stable pulse wave recordings was taken into account, that is, a mean of 5-12 pulse wave complexes. The depicted pulse transit time represents the mean of these 5-12 complexes. Only the assessments with a confidence interval ,10% of this mean value were considered valid for the study.
The sequence of measurements, after a 10 min rest in the supine position, was as follows: radial pressure wave recording, AP1, carotid pressure wave recording, AP2, femoral pressure wave recording, and distance assessment. The anaesthetist was blinded to the stiffness evaluation results.
Intake of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers were stopped 24 and 48 h, respectively, before the procedure. 19 Monitoring included electrocardiography, pulse oximetry, non-invasive AP, bispectral index (BIS TM , Aspect Medical Systems Inc., Newton, MA, USA), end-tidal carbon dioxide, oxygen concentration, and neuromuscular block. Anaesthesia was induced with propofol and remifentanil administered in target-controlled infusion (TCI) using the infusion Orchestra w Base Primea system (Fresenius Kabi, France). The population pharmacokinetic sets of Minto and colleagues' model 20 and Schnider and colleagues' model 21 were selected for remifentanil and propofol, respectively. Propofol was initiated to achieve an effect-site concentration of 3 mg ml 21 , and subsequently titrated so as to maintain BIS values between 40 and 50. Remifentanil infusion was initiated with a target of 4 ng ml 21 . Tracheal intubation was facilitated by cisatracurium 0.15 mg kg 21 . During anaesthesia induction, if AP decreased more than 20% of baseline (APc), ephedrine 9 mg was administered along with hydroxyethyl starch 500 ml. Ephedrine bolus (9 mg) was repeated every 5 min until AP was restored. Ephedrine was not administered in patients with pre-existing cardiovascular history. HR and AP were recorded every 150 s during anaesthesia induction, for 30 min. This period included the oro-tracheal intubation in all patients, but not the surgical intervention. Doses of propofol, remifentanil, cisatracurium, ephedrine, and hydroxyethyl starch were recorded in each patient. Total drug doses during anaesthesia induction (total propofol and total remifentanil) were used for analysis. In order to describe the rate of drug administration, possibly implicated in the risk of hypotension, drug dosages administered at the 5th min were also used for analytical purposes.
Haemodynamic variations during anaesthesia induction were evaluated: the changes in systolic AP (diffSAP), diastolic AP (diffDAP), and HR (diffHR) were defined as the difference between baseline SAP, DAP, and HR at the onset of anaesthesia induction and the lowest value of SAP, DAP, and HR during anaesthesia induction. The differences between baseline preoperative anaesthetic evaluation values of SAP, DAP, and HR and minimal values of SAP, DAP, and HR during anaesthesia induction were analysed separately.
Statistics
Statistical analyses were performed using NCSS software (Kaysville, UT, USA). Continuous variables are presented as means (SD), along with minimum and maximum values, whereas the other variables are expressed as percentages. Relationships between the various variables were assessed by bivariate analysis (linear regression). The mean values were compared using Student's t-test. The association between c -fPWV and AP variations during induction of anaesthesia was assessed by considering c -fPWV as continuous, then a categorical variable (high vs normal). For this latter classification, a threshold of c -fPWV value of 12.9 m s 21 was used, which corresponds to the upper limit of the 95th percentile of the reference values established with the PulsePen device in normal elderly subjects. 22 Multivariate forward stepwise analysis was performed to assess the determinants of changes in SAP during anaesthesia. A value of P,0.05 was considered as statistically significant.
Results
A total of 45 patients were included in the study (62% females). Two patients, an obese woman (BMI 37.9) in whom femoral PP assessment was technically impossible and another with a consistent variation in AP (.15%) between the two measurements, were not selected. Of the 45 patients, 30 were ASA I, 13 ASA II, and two ASA III. Patients with ASA class I and II were ambulatory while ASA III patients were in-hospital. In this series, three patients had a history of stroke, four had coronary artery disease, five had pulmonary disease, and one had renal disease. with age (r¼0.52, P,0.01). AP was assessed at pre-surgical anaesthetic evaluation (APc) and monitored during anaesthesia induction (APa), as was HR. As presented in Table 1 , compared with the haemodynamic variables assessed at preoperative evaluation, the baseline values before anaesthesia induction showed an increase in SAP, DAP, MAP, and HR. The difference observed between the two measurements did not correlate with either age or arterial stiffness (data not shown). Nevertheless, the decrease in SAP during anaesthesia induction correlated with preoperative SAP in bivariate analysis (data not shown). During induction of anaesthesia, propofol and remifentanil were administered at total mean dosages of 404.4 (126.0) mg and 243.2 (82.6) mg, respectively. In this study, 37 (82%) patients had greater decreases in SAP than the expected threshold. Among this group, seven patients had cardiovascular history and did not receive ephedrine. Thirty patients received 1.46 (0.83) boluses of ephedrine 9 mg, whereas 19 others received hydroxyethyl starch. Table 2 presents the main characteristics of anaesthesia induction relative to the BIS values and haemodynamic changes.
Bivariate analyses, performed to test the relationship between the decreases in SAP and age, PWV, BIS minimal, and total propofol, remifentanil, or propofol and remifentanil Arterial stiffness and hypotension BJA administered at the 5th min, found only age and PWV to be significantly associated with the decreases in SAP (Fig. 1) . The maximum decrease in SAP (diffSAP) correlated with both age [ Fig. 1 In order to define the independent role of c -f PWV in SAP decreases during induction of anaesthesia, a forward stepwise regression analysis was also conducted which included PWV, age, ASA score, and history of cardiovascular events. Analysis revealed that only c -fPWV significantly influenced SAP variation during anaesthesia induction (r 2 ¼12.7%, Table 3 ). Finally, the sensitivity and specificity of PWV to predict a severe decrease in SAP (.70 mm Hg) were tested using the threshold of 12.9 m s 21 , with Se¼50% and Sp¼74%.
Discussion
To our knowledge, this is the first study demonstrating that aortic stiffness, assessed by c -fPWV during preoperative anaesthetic evaluation, is associated with the magnitude of the SAP decrease during anaesthesia induction with propofol/remifentanil. The association between PWV and the variation in SAP (diffSAP) was statistically significant after taking into account several parameters such as age, ASA class, preexisting cardiovascular problems, doses and rate of administration of anaesthetic drugs, and depth of anaesthesia (assessed by BIS monitoring). In addition to patient age, PWV was the only variable found to correlate with the maximum decrease in SAP.
The association between PWV and SAP-decrease during induction of anaesthesia was also found when the population was subdivided into the 'normal' or 'high' aortic stiffness group according to the thresholds recently identified in a reference group of elderly subjects, in which PWV was measured with the same device as the one used in the present study. 22 Subjects classified in the high aortic stiffness group showed 25% more pronounced decrease in SAP during anaesthesia induction. Among the different clinical and biological parameters, only c -fPWV significantly correlated with the decrease in SAP in both univariate and multivariate analyses. These results suggest that evaluation of PWV may be a better 'high borderline' value for this age. 22 PWV provides a valid reflection of arterial ageing, increased arterial stiffness being responsible for impaired ability of AP regulation, particularly in stressful conditions. 10 11 Therefore, in this study, PWV appears to be useful, since in multivariate analyses, the correlation between PWV and the magnitude of the decrease in SAP persisted, despite adjustments for age. The choice of the anaesthetic regimen is based on the fact that TCI takes into account several confounding factors such as age, body mass, and gender and allows the calculation of the effect-site concentration. Although the clinical benefit of TCI is still a matter of debate, its safety is acceptable, and there is no evidence that its haemodynamic tolerance is worse than that of a manually injected regimen (Cochrane). The choice of propofol could be criticized in elderly patients. When compared with a manual infusion of etomidate, the i.v. hypnotic considered to have the most limited cardiovascular effects, the TCI of propofol had similar haemodynamic profile. 23 We therefore believe that the anaesthetic regimen used in this study, as previously documented, 21 should not change the conclusions of the present work. In order to allow clinicians who do not use TCI routinely to extrapolate our results, we translated the TCI parameters into doses used for induction and immediate post-induction period (provide mg kg 21 for the bolus and the infusion rates for the first 30 min). Within this population of patients, the use of BIS was intended to avoid heterogeneity in terms of depth of anaesthesia. The time to peak effect on AP and HR is delayed when compared with the BIS value; 24 at least 15 min should be allowed after induction in order to estimate the maximum effect of an anaesthetic regimen on AP. Therefore, a 30 min period was chosen for monitoring. Previous studies have investigated the possible role of arterial stiffness in hypotension during anaesthesia in younger patients. 13 -15 However, the results of these studies have not been conclusive. This may be explained by the more pronounced involvement of arterial stiffness in elderly patients. Nevertheless, the magnitude of the variation of the AP during anaesthesia induction may depend on many factors, both arterial and extra-arterial. In the present study, the variation in SAP was not correlated with drug doses, but with the preoperative SAP level, as previously described. 25 Moreover, pre-anaesthesia SAP values were not correlated with either patient age or arterial stiffness.
In conclusion, the present study shows that c-fPWV measured before surgery is a useful predictor of AP instability during anaesthesia induction, and may add extra value to the criteria which are currently used for the prediction of risks during anaesthesia such as age, ASA score, history of cardiovascular events, BIS, and drug quantity. Moreover, c-fPWV measured with the PulsePen device represents a rapid, simple, and non-invasive evaluation which could be introduced systematically during preoperative anaesthetic evaluation for assessment of haemodynamic instability and anaesthetic cardiovascular risk, particularly in patients with undetermined or low risk. Thus, c-fPWV measurement may represent a valuable tool in assessing risk before scheduled surgery. 
